Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan effect on insulin sensitivity in CHF
NCT00347087Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Irbesartan with Placebo (2 arms). Primary endpoint: Insulin sensitivity assessment using intravenous glucose tolerance testing at 3 months. Started Jul 2004; status: completed.
02
Drugs
irbesartan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00347087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347087.